BSEInsider Trading / SAST3h ago · 25 Sept 2026, 03:45 pm

Intimation regarding Closure of Trading Window

Sun Pharma Advanced Research Company Ltd · 532872

✦ AI Summaryinsider_trading

Sun Pharma Advanced Research Company Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10

Growth Catalyst3/10

Governance Concern2/10

Regulatory Risk4/10

Balance Sheet Risk2/10

Liquidity Impact8/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

Sun Pharma Advanced Research Company Ltd - 532872 - Closure of Trading Window

Attachments (1)

📄

1a375851-405a-4ae7-8a43-e91c3b1e26c0.pdf

pdf

Download →

View document text

SPARC/Sec/SE/2026-27/39 September 25, 2026 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. Scrip Symbol: SPARC Scrip Code: 532872 Dear Sir/ Madam, Sub: Intimation for Closure of Trading Window Pursuant to the Company’s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in Company’s shares shall remain closed during the period starting from October 01, 2026, till 48 hours after the declaration of Unaudited Financial Results for the second quarter and half year ended September 30, 2026. The date of Board Meeting to approve the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2026 shall be intimated in due course. This is for your information and record. For Sun Pharma Advanced Research Company Limited Kajal Damania Company Secretary and Compliance Officer